| Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma XM Lao, G Luo, LT Ye, C Luo, M Shi, D Wang, R Guo, M Chen, S Li, X Lin, ... Liver International 33 (4), 595-604, 2013 | 121 | 2013 |
| Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients G Liu, J Zhu, M Yu, C Cai, Y Zhou, M Yu, Z Fu, Y Gong, B Yang, Y Li, ... Journal of translational medicine 13, 1-10, 2015 | 112 | 2015 |
| Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner S Zheng, H Chen, Y Wang, W Gao, Z Fu, Q Zhou, Y Jiang, Q Lin, L Tan, ... Cancer letters 371 (2), 354-365, 2016 | 66 | 2016 |
| FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma H Ye, Q Zhou, S Zheng, G Li, Q Lin, L Ye, Y Wang, L Wei, X Zhao, W Li, ... Cell death & disease 9 (2), 34, 2018 | 54 | 2018 |
| The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma L Ye, J Mayerle, A Ziesch, FP Reiter, AL Gerbes, EN De Toni Cell death discovery 5 (1), 86, 2019 | 52 | 2019 |
| A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: new proposal for low-and high-grade groups, validation of a nomogram for … L Ye, H Ye, Q Zhou, Z Li, Q Lin, L Tan, W Gao, Z Fu, S Zheng, R Chen International Journal of Surgery 29, 108-117, 2016 | 26 | 2016 |
| Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model FP Reiter, L Ye, F Bösch, R Wimmer, R Artmann, A Ziesch, V Kanitz, ... Laboratory investigation 99 (12), 1906-1917, 2019 | 25 | 2019 |
| Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells FP Reiter, G Denk, A Ziesch, A Ofner, R Wimmer, S Hohenester, ... Cellular Oncology 42, 705-715, 2019 | 23 | 2019 |
| Advances in pharmacotherapy of hepatocellular carcinoma: a state-of-the-art review FP Reiter, N Ben Khaled, L Ye, C Zhang, M Seidensticker, ... Digestive Diseases 40 (5), 565-580, 2022 | 11 | 2022 |
| Prognostic significance and functional relevance of olfactomedin 4 in early-stage hepatocellular carcinoma L Ye, L Kriegl, FP Reiter, SM Munker, T Itzel, A Teufel, A Ziesch, HP Török, ... Clinical and Translational Gastroenterology 11 (1), e00124, 2020 | 11 | 2020 |
| Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management L Ye, J Schneider, P Schirmacher, C Seifert, L Frey, Y He, A Geier, ... Liver Cancer 13 (1), 6-28, 2023 | 7 | 2023 |
| Durable complete response of brain metastasis from hepatocellular carcinoma on treatment with nivolumab and radiation treatment L Ye, C Zhang, M Seidensticker, J Mayerle, FP Reiter, EN De Toni Official journal of the American College of Gastroenterology| ACG 115 (12 …, 2020 | 7 | 2020 |
| p70 ribosomal protein S6 kinase is a checkpoint of human hepatic stellate cell activation and liver fibrosis in mice FP Reiter, L Ye, A Ofner, TS Schiergens, A Ziesch, L Brandl, NB Khaled, ... Cellular and Molecular Gastroenterology and Hepatology 13 (1), 95-112, 2022 | 6 | 2022 |
| The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/-Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology L Ye, A Ziesch, JS Schneider, A Ofner, H Nieß, G Denk, S Hohenester, ... Aging and Disease 15 (1), 338, 2024 | 4 | 2024 |
| Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events NB Khaled, M Möller, LS Jochheim, C Leyh, U Ehmer, K Böttcher, ... JHEP Reports 6 (6), 101065, 2024 | 2 | 2024 |
| TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status N Ben Khaled, K Hammer, L Ye, A Alnatsha, SA Widholz, I Piseddu, S Sirtl, ... Cancers 14 (21), 5240, 2022 | 2 | 2022 |
| Comparative response of HCC Cells to TKIs: modified in vitro testing and descriptive expression analysis P Sagmeister, J Daza, A Ofner, A Ziesch, L Ye, N Ben Khaled, M Ebert, ... Journal of Hepatocellular Carcinoma, 595-607, 2022 | 2 | 2022 |
| Expression, cellular distribution, and prognostic relevance of olfactomedin 4 in hepatocellular carcinoma L Ye, L Brandl, J Mayerle, T Kirchner, AL Gerbes, EN De Toni Zeitschrift für Gastroenterologie 56 (08), KV 300, 2018 | 1 | 2018 |
| The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma (HCC) L Ye, J Mayerle, A Ziesch, K Wei, AL Gerbes, EN De Toni Zeitschrift für Gastroenterologie 56 (05), G3, 2018 | 1 | 2018 |
| Prognostic significance of platelet count in HCC patients adjusted for surrogate parameters of portal hypertension I Rodriguez, EN De Toni, K Bernhart, T Itzel, N Ben-Khaled, M Findik, ... Zeitschrift für Gastroenterologie 62 (05), K10, 2024 | | 2024 |
Enrico N. De ToniProfessor of Medicine, University of MunichVerifisert e-postadresse på med.uni-muenchen.de